IONS: Ionis Pharmaceuticals, Inc. Common Stock Company Profile & Statistics

Ionis Pharmaceuticals, Inc. Common Stock Profile

About

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Info & Links

CEO

Brett P. Monia

Headquarters

2855 GAZELLE COURT
CARLSBAD, CA 92010, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

447

Employees

1,069

Ionis Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

12.04B

Enterprise Value

13.00B

Enterprise Value/EBITDA(ttm)

-48.17

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

12.19

Price to Book(mrq)

19.10

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

98.70%

Operating Margin(ttm)

-26.45%

Profit Margin(ttm)

-53.11%

Return on Equity(ttm)

-44.26%

Return on Invested Capital(ttm)

-14.97%

Return on Assets(ttm)

-8.65%

Income Statement

Revenue(ttm)

944.05M

Revenue Per Share(ttm)

5.92

Gross Profit(ttm)

933.54M

EBITDA(ttm)³

-269.84M

Net Income Available to Common(ttm)

-268.22M

Diluted EPS(ttm)

-1.69

Share Statistics

Beta (5Y Monthly)

0.33

52-Week Change

89.81%

S&P 500 52-Week Change

12.51%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

159.39M

Dividend Yield

0.00%

Float⁴

157.76M

% Held by Insiders

2.60%

% Held by Institutions

93.86%

Balance Sheet

Total Cash(mrq)

2.29B

Total Cash Per Share(mrq)

14.37

Total Debt(mrq)

1.26B

Total Debt/Equity(mrq)

198.53%

Current Ratio(mrq)

2.79%

Quick Ratio(mrq)

2.78%

Book Value Per Share(mrq)

3.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.82

Free Cash Flow(ytd)

-161.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IONS

Ionis Pharmaceuticals, Inc. Common Stock